This VDAC1/HK2 association entails multiple advantages to cancer cells: a) blocks pro-apoptotic signals; b) fuels glycolysis with a continuous flux of mitochondrial ATP; and c) reduces sensitivity to feedback inhibition by HK2 product, glucose-6-phosphate. Here, VDAC1 is linked to cancer.